nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP3A4—bone cancer	0.732	1	CbGaD
Diltiazem—CACNA1S—pes—bone cancer	0.00243	0.76	CbGeAlD
Diltiazem—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00172	0.0413	CbGpPWpGaD
Diltiazem—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00124	0.0299	CbGpPWpGaD
Diltiazem—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00107	0.0259	CbGpPWpGaD
Diltiazem—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00103	0.0247	CbGpPWpGaD
Diltiazem—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000959	0.0231	CbGpPWpGaD
Diltiazem—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00094	0.0226	CbGpPWpGaD
Diltiazem—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000886	0.0213	CbGpPWpGaD
Diltiazem—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000882	0.0212	CbGpPWpGaD
Diltiazem—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00088	0.0212	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000879	0.0212	CbGpPWpGaD
Diltiazem—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000874	0.0211	CbGpPWpGaD
Diltiazem—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000836	0.0201	CbGpPWpGaD
Diltiazem—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000828	0.0199	CbGpPWpGaD
Diltiazem—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000796	0.0192	CbGpPWpGaD
Diltiazem—CACNA1S—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.00075	0.0181	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000738	0.0178	CbGpPWpGaD
Diltiazem—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000623	0.015	CbGpPWpGaD
Diltiazem—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000598	0.0144	CbGpPWpGaD
Diltiazem—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000576	0.0139	CbGpPWpGaD
Diltiazem—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000576	0.0139	CbGpPWpGaD
Diltiazem—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000542	0.0131	CbGpPWpGaD
Diltiazem—CACNA1C—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000535	0.0129	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000534	0.0129	CbGpPWpGaD
Diltiazem—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000518	0.0125	CbGpPWpGaD
Diltiazem—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000514	0.0124	CbGpPWpGaD
Diltiazem—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000509	0.0123	CbGpPWpGaD
Diltiazem—CACNA1C—Regulation of insulin secretion—GNA11—bone cancer	0.000507	0.0122	CbGpPWpGaD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000506	0.0122	CbGpPWpGaD
Diltiazem—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000498	0.012	CbGpPWpGaD
Diltiazem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000472	0.0114	CbGpPWpGaD
Diltiazem—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000463	0.0111	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000462	0.0111	CbGpPWpGaD
Diltiazem—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000445	0.0107	CbGpPWpGaD
Diltiazem—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000426	0.0102	CbGpPWpGaD
Diltiazem—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000422	0.0102	CbGpPWpGaD
Diltiazem—CACNA1S—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000419	0.0101	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000413	0.00994	CbGpPWpGaD
Diltiazem—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000411	0.0099	CbGpPWpGaD
Diltiazem—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000409	0.00986	CbGpPWpGaD
Diltiazem—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000406	0.00183	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000406	0.00183	CcSEcCtD
Diltiazem—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000406	0.00977	CbGpPWpGaD
Diltiazem—Decreased appetite—Cisplatin—bone cancer	0.000405	0.00183	CcSEcCtD
Diltiazem—Bronchitis—Epirubicin—bone cancer	0.000405	0.00183	CcSEcCtD
Diltiazem—CACNG1—tendon—bone cancer	0.000405	0.127	CbGeAlD
Diltiazem—Nasopharyngitis—Doxorubicin—bone cancer	0.000403	0.00182	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Cisplatin—bone cancer	0.000402	0.00182	CcSEcCtD
Diltiazem—CACNA1C—Integration of energy metabolism—GNA11—bone cancer	0.000399	0.0096	CbGpPWpGaD
Diltiazem—Pain—Cisplatin—bone cancer	0.000399	0.0018	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000398	0.00179	CcSEcCtD
Diltiazem—Renal failure—Methotrexate—bone cancer	0.000394	0.00178	CcSEcCtD
Diltiazem—Abdominal distension—Doxorubicin—bone cancer	0.000392	0.00177	CcSEcCtD
Diltiazem—Conjunctivitis—Methotrexate—bone cancer	0.00039	0.00176	CcSEcCtD
Diltiazem—Influenza—Doxorubicin—bone cancer	0.000389	0.00176	CcSEcCtD
Diltiazem—Pollakiuria—Epirubicin—bone cancer	0.000389	0.00176	CcSEcCtD
Diltiazem—Sweating—Methotrexate—bone cancer	0.000384	0.00174	CcSEcCtD
Diltiazem—Photosensitivity reaction—Epirubicin—bone cancer	0.000384	0.00173	CcSEcCtD
Diltiazem—Feeling abnormal—Cisplatin—bone cancer	0.000384	0.00173	CcSEcCtD
Diltiazem—Weight increased—Epirubicin—bone cancer	0.000383	0.00173	CcSEcCtD
Diltiazem—Hyperglycaemia—Epirubicin—bone cancer	0.00038	0.00171	CcSEcCtD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000379	0.00914	CbGpPWpGaD
Diltiazem—Epistaxis—Methotrexate—bone cancer	0.000378	0.00171	CcSEcCtD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000376	0.00906	CbGpPWpGaD
Diltiazem—CYP2C9—Cisplatin—bone cancer	0.000375	0.235	CbGbCtD
Diltiazem—Bronchitis—Doxorubicin—bone cancer	0.000375	0.00169	CcSEcCtD
Diltiazem—Agranulocytosis—Methotrexate—bone cancer	0.000374	0.00169	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000372	0.00168	CcSEcCtD
Diltiazem—Renal failure—Epirubicin—bone cancer	0.000369	0.00167	CcSEcCtD
Diltiazem—Body temperature increased—Cisplatin—bone cancer	0.000368	0.00166	CcSEcCtD
Diltiazem—Neuropathy peripheral—Epirubicin—bone cancer	0.000368	0.00166	CcSEcCtD
Diltiazem—Conjunctivitis—Epirubicin—bone cancer	0.000365	0.00165	CcSEcCtD
Diltiazem—Urinary tract infection—Epirubicin—bone cancer	0.000365	0.00165	CcSEcCtD
Diltiazem—ABCB1—Cisplatin—bone cancer	0.000364	0.228	CbGbCtD
Diltiazem—Hepatitis—Methotrexate—bone cancer	0.00036	0.00163	CcSEcCtD
Diltiazem—Sweating—Epirubicin—bone cancer	0.00036	0.00162	CcSEcCtD
Diltiazem—Pollakiuria—Doxorubicin—bone cancer	0.00036	0.00162	CcSEcCtD
Diltiazem—Pharyngitis—Methotrexate—bone cancer	0.000357	0.00161	CcSEcCtD
Diltiazem—Urinary tract disorder—Methotrexate—bone cancer	0.000356	0.0016	CcSEcCtD
Diltiazem—Photosensitivity reaction—Doxorubicin—bone cancer	0.000356	0.0016	CcSEcCtD
Diltiazem—Weight increased—Doxorubicin—bone cancer	0.000354	0.0016	CcSEcCtD
Diltiazem—Epistaxis—Epirubicin—bone cancer	0.000354	0.0016	CcSEcCtD
Diltiazem—Urethral disorder—Methotrexate—bone cancer	0.000353	0.00159	CcSEcCtD
Diltiazem—Sinusitis—Epirubicin—bone cancer	0.000352	0.00159	CcSEcCtD
Diltiazem—Hyperglycaemia—Doxorubicin—bone cancer	0.000351	0.00159	CcSEcCtD
Diltiazem—Agranulocytosis—Epirubicin—bone cancer	0.00035	0.00158	CcSEcCtD
Diltiazem—Visual impairment—Methotrexate—bone cancer	0.000347	0.00157	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000344	0.00155	CcSEcCtD
Diltiazem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000344	0.00828	CbGpPWpGaD
Diltiazem—Hypersensitivity—Cisplatin—bone cancer	0.000343	0.00155	CcSEcCtD
Diltiazem—Bradycardia—Epirubicin—bone cancer	0.000343	0.00155	CcSEcCtD
Diltiazem—Renal failure—Doxorubicin—bone cancer	0.000341	0.00154	CcSEcCtD
Diltiazem—Erythema multiforme—Methotrexate—bone cancer	0.00034	0.00154	CcSEcCtD
Diltiazem—Neuropathy peripheral—Doxorubicin—bone cancer	0.00034	0.00154	CcSEcCtD
Diltiazem—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000339	0.00817	CbGpPWpGaD
Diltiazem—Rhinitis—Epirubicin—bone cancer	0.000338	0.00152	CcSEcCtD
Diltiazem—Urinary tract infection—Doxorubicin—bone cancer	0.000338	0.00152	CcSEcCtD
Diltiazem—Conjunctivitis—Doxorubicin—bone cancer	0.000338	0.00152	CcSEcCtD
Diltiazem—Hepatitis—Epirubicin—bone cancer	0.000337	0.00152	CcSEcCtD
Diltiazem—Eye disorder—Methotrexate—bone cancer	0.000336	0.00152	CcSEcCtD
Diltiazem—Tinnitus—Methotrexate—bone cancer	0.000336	0.00152	CcSEcCtD
Diltiazem—Asthenia—Cisplatin—bone cancer	0.000334	0.00151	CcSEcCtD
Diltiazem—Pharyngitis—Epirubicin—bone cancer	0.000334	0.00151	CcSEcCtD
Diltiazem—Cardiac disorder—Methotrexate—bone cancer	0.000334	0.00151	CcSEcCtD
Diltiazem—Sweating—Doxorubicin—bone cancer	0.000333	0.0015	CcSEcCtD
Diltiazem—Urinary tract disorder—Epirubicin—bone cancer	0.000333	0.0015	CcSEcCtD
Diltiazem—Oedema peripheral—Epirubicin—bone cancer	0.000332	0.0015	CcSEcCtD
Diltiazem—Urethral disorder—Epirubicin—bone cancer	0.00033	0.00149	CcSEcCtD
Diltiazem—Epistaxis—Doxorubicin—bone cancer	0.000328	0.00148	CcSEcCtD
Diltiazem—Angiopathy—Methotrexate—bone cancer	0.000327	0.00147	CcSEcCtD
Diltiazem—Sinusitis—Doxorubicin—bone cancer	0.000326	0.00147	CcSEcCtD
Diltiazem—Visual impairment—Epirubicin—bone cancer	0.000325	0.00147	CcSEcCtD
Diltiazem—Mediastinal disorder—Methotrexate—bone cancer	0.000324	0.00146	CcSEcCtD
Diltiazem—Agranulocytosis—Doxorubicin—bone cancer	0.000324	0.00146	CcSEcCtD
Diltiazem—Diarrhoea—Cisplatin—bone cancer	0.000319	0.00144	CcSEcCtD
Diltiazem—Erythema multiforme—Epirubicin—bone cancer	0.000319	0.00144	CcSEcCtD
Diltiazem—Alopecia—Methotrexate—bone cancer	0.000318	0.00144	CcSEcCtD
Diltiazem—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000318	0.00765	CbGpPWpGaD
Diltiazem—Bradycardia—Doxorubicin—bone cancer	0.000317	0.00143	CcSEcCtD
Diltiazem—Eye disorder—Epirubicin—bone cancer	0.000315	0.00142	CcSEcCtD
Diltiazem—Tinnitus—Epirubicin—bone cancer	0.000314	0.00142	CcSEcCtD
Diltiazem—Erythema—Methotrexate—bone cancer	0.000313	0.00141	CcSEcCtD
Diltiazem—Malnutrition—Methotrexate—bone cancer	0.000313	0.00141	CcSEcCtD
Diltiazem—Flushing—Epirubicin—bone cancer	0.000313	0.00141	CcSEcCtD
Diltiazem—Cardiac disorder—Epirubicin—bone cancer	0.000313	0.00141	CcSEcCtD
Diltiazem—Rhinitis—Doxorubicin—bone cancer	0.000313	0.00141	CcSEcCtD
Diltiazem—Hepatitis—Doxorubicin—bone cancer	0.000312	0.00141	CcSEcCtD
Diltiazem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000311	0.0075	CbGpPWpGaD
Diltiazem—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00031	0.00747	CbGpPWpGaD
Diltiazem—Pharyngitis—Doxorubicin—bone cancer	0.000309	0.0014	CcSEcCtD
Diltiazem—Urinary tract disorder—Doxorubicin—bone cancer	0.000308	0.00139	CcSEcCtD
Diltiazem—Oedema peripheral—Doxorubicin—bone cancer	0.000307	0.00139	CcSEcCtD
Diltiazem—Dysgeusia—Methotrexate—bone cancer	0.000307	0.00139	CcSEcCtD
Diltiazem—Angiopathy—Epirubicin—bone cancer	0.000306	0.00138	CcSEcCtD
Diltiazem—Urethral disorder—Doxorubicin—bone cancer	0.000306	0.00138	CcSEcCtD
Diltiazem—Mediastinal disorder—Epirubicin—bone cancer	0.000304	0.00137	CcSEcCtD
Diltiazem—Arrhythmia—Epirubicin—bone cancer	0.000301	0.00136	CcSEcCtD
Diltiazem—Visual impairment—Doxorubicin—bone cancer	0.0003	0.00136	CcSEcCtD
Diltiazem—CACNA1C—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000299	0.0072	CbGpPWpGaD
Diltiazem—Alopecia—Epirubicin—bone cancer	0.000298	0.00134	CcSEcCtD
Diltiazem—Vomiting—Cisplatin—bone cancer	0.000296	0.00134	CcSEcCtD
Diltiazem—Vision blurred—Methotrexate—bone cancer	0.000295	0.00133	CcSEcCtD
Diltiazem—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000295	0.00711	CbGpPWpGaD
Diltiazem—Erythema multiforme—Doxorubicin—bone cancer	0.000295	0.00133	CcSEcCtD
Diltiazem—Rash—Cisplatin—bone cancer	0.000294	0.00133	CcSEcCtD
Diltiazem—Dermatitis—Cisplatin—bone cancer	0.000294	0.00133	CcSEcCtD
Diltiazem—Erythema—Epirubicin—bone cancer	0.000293	0.00132	CcSEcCtD
Diltiazem—Malnutrition—Epirubicin—bone cancer	0.000293	0.00132	CcSEcCtD
Diltiazem—Eye disorder—Doxorubicin—bone cancer	0.000291	0.00132	CcSEcCtD
Diltiazem—Ill-defined disorder—Methotrexate—bone cancer	0.000291	0.00131	CcSEcCtD
Diltiazem—Tinnitus—Doxorubicin—bone cancer	0.000291	0.00131	CcSEcCtD
Diltiazem—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00029	0.00698	CbGpPWpGaD
Diltiazem—Flushing—Doxorubicin—bone cancer	0.000289	0.00131	CcSEcCtD
Diltiazem—Cardiac disorder—Doxorubicin—bone cancer	0.000289	0.00131	CcSEcCtD
Diltiazem—Flatulence—Epirubicin—bone cancer	0.000289	0.0013	CcSEcCtD
Diltiazem—Tension—Epirubicin—bone cancer	0.000288	0.0013	CcSEcCtD
Diltiazem—Dysgeusia—Epirubicin—bone cancer	0.000287	0.0013	CcSEcCtD
Diltiazem—Nervousness—Epirubicin—bone cancer	0.000285	0.00129	CcSEcCtD
Diltiazem—Angiopathy—Doxorubicin—bone cancer	0.000283	0.00128	CcSEcCtD
Diltiazem—Malaise—Methotrexate—bone cancer	0.000283	0.00128	CcSEcCtD
Diltiazem—Muscle spasms—Epirubicin—bone cancer	0.000282	0.00127	CcSEcCtD
Diltiazem—Vertigo—Methotrexate—bone cancer	0.000282	0.00127	CcSEcCtD
Diltiazem—Mediastinal disorder—Doxorubicin—bone cancer	0.000281	0.00127	CcSEcCtD
Diltiazem—Leukopenia—Methotrexate—bone cancer	0.000281	0.00127	CcSEcCtD
Diltiazem—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000279	0.00671	CbGpPWpGaD
Diltiazem—Arrhythmia—Doxorubicin—bone cancer	0.000279	0.00126	CcSEcCtD
Diltiazem—Nausea—Cisplatin—bone cancer	0.000277	0.00125	CcSEcCtD
Diltiazem—Vision blurred—Epirubicin—bone cancer	0.000276	0.00125	CcSEcCtD
Diltiazem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000276	0.00665	CbGpPWpGaD
Diltiazem—Alopecia—Doxorubicin—bone cancer	0.000275	0.00124	CcSEcCtD
Diltiazem—Cough—Methotrexate—bone cancer	0.000273	0.00123	CcSEcCtD
Diltiazem—Ill-defined disorder—Epirubicin—bone cancer	0.000272	0.00123	CcSEcCtD
Diltiazem—Malnutrition—Doxorubicin—bone cancer	0.000271	0.00123	CcSEcCtD
Diltiazem—Erythema—Doxorubicin—bone cancer	0.000271	0.00123	CcSEcCtD
Diltiazem—Flatulence—Doxorubicin—bone cancer	0.000267	0.00121	CcSEcCtD
Diltiazem—Arthralgia—Methotrexate—bone cancer	0.000267	0.0012	CcSEcCtD
Diltiazem—Myalgia—Methotrexate—bone cancer	0.000267	0.0012	CcSEcCtD
Diltiazem—Chest pain—Methotrexate—bone cancer	0.000267	0.0012	CcSEcCtD
Diltiazem—Tension—Doxorubicin—bone cancer	0.000266	0.0012	CcSEcCtD
Diltiazem—Dysgeusia—Doxorubicin—bone cancer	0.000266	0.0012	CcSEcCtD
Diltiazem—Malaise—Epirubicin—bone cancer	0.000265	0.00119	CcSEcCtD
Diltiazem—Discomfort—Methotrexate—bone cancer	0.000264	0.00119	CcSEcCtD
Diltiazem—Nervousness—Doxorubicin—bone cancer	0.000264	0.00119	CcSEcCtD
Diltiazem—Vertigo—Epirubicin—bone cancer	0.000264	0.00119	CcSEcCtD
Diltiazem—Syncope—Epirubicin—bone cancer	0.000263	0.00119	CcSEcCtD
Diltiazem—Leukopenia—Epirubicin—bone cancer	0.000263	0.00119	CcSEcCtD
Diltiazem—Muscle spasms—Doxorubicin—bone cancer	0.000261	0.00118	CcSEcCtD
Diltiazem—Palpitations—Epirubicin—bone cancer	0.000259	0.00117	CcSEcCtD
Diltiazem—Loss of consciousness—Epirubicin—bone cancer	0.000258	0.00116	CcSEcCtD
Diltiazem—Cough—Epirubicin—bone cancer	0.000256	0.00116	CcSEcCtD
Diltiazem—Vision blurred—Doxorubicin—bone cancer	0.000256	0.00115	CcSEcCtD
Diltiazem—Infection—Methotrexate—bone cancer	0.000254	0.00115	CcSEcCtD
Diltiazem—Ill-defined disorder—Doxorubicin—bone cancer	0.000252	0.00114	CcSEcCtD
Diltiazem—Nervous system disorder—Methotrexate—bone cancer	0.000251	0.00113	CcSEcCtD
Diltiazem—Thrombocytopenia—Methotrexate—bone cancer	0.00025	0.00113	CcSEcCtD
Diltiazem—Chest pain—Epirubicin—bone cancer	0.00025	0.00113	CcSEcCtD
Diltiazem—Myalgia—Epirubicin—bone cancer	0.00025	0.00113	CcSEcCtD
Diltiazem—Arthralgia—Epirubicin—bone cancer	0.00025	0.00113	CcSEcCtD
Diltiazem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000248	0.00598	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000248	0.00598	CbGpPWpGaD
Diltiazem—Hyperhidrosis—Methotrexate—bone cancer	0.000247	0.00112	CcSEcCtD
Diltiazem—Discomfort—Epirubicin—bone cancer	0.000247	0.00111	CcSEcCtD
Diltiazem—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000245	0.00591	CbGpPWpGaD
Diltiazem—Malaise—Doxorubicin—bone cancer	0.000245	0.0011	CcSEcCtD
Diltiazem—Dry mouth—Epirubicin—bone cancer	0.000244	0.0011	CcSEcCtD
Diltiazem—ABCB1—Doxorubicin—bone cancer	0.000244	0.153	CbGbCtD
Diltiazem—Vertigo—Doxorubicin—bone cancer	0.000244	0.0011	CcSEcCtD
Diltiazem—Anorexia—Methotrexate—bone cancer	0.000244	0.0011	CcSEcCtD
Diltiazem—Syncope—Doxorubicin—bone cancer	0.000243	0.0011	CcSEcCtD
Diltiazem—Leukopenia—Doxorubicin—bone cancer	0.000243	0.0011	CcSEcCtD
Diltiazem—Palpitations—Doxorubicin—bone cancer	0.00024	0.00108	CcSEcCtD
Diltiazem—Oedema—Epirubicin—bone cancer	0.000239	0.00108	CcSEcCtD
Diltiazem—Hypotension—Methotrexate—bone cancer	0.000239	0.00108	CcSEcCtD
Diltiazem—Loss of consciousness—Doxorubicin—bone cancer	0.000239	0.00108	CcSEcCtD
Diltiazem—Infection—Epirubicin—bone cancer	0.000238	0.00107	CcSEcCtD
Diltiazem—Cough—Doxorubicin—bone cancer	0.000237	0.00107	CcSEcCtD
Diltiazem—ABCB1—Methotrexate—bone cancer	0.000236	0.148	CbGbCtD
Diltiazem—Shock—Epirubicin—bone cancer	0.000236	0.00106	CcSEcCtD
Diltiazem—Nervous system disorder—Epirubicin—bone cancer	0.000235	0.00106	CcSEcCtD
Diltiazem—Thrombocytopenia—Epirubicin—bone cancer	0.000234	0.00106	CcSEcCtD
Diltiazem—Tachycardia—Epirubicin—bone cancer	0.000234	0.00105	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000233	0.00105	CcSEcCtD
Diltiazem—Hyperhidrosis—Epirubicin—bone cancer	0.000231	0.00104	CcSEcCtD
Diltiazem—Insomnia—Methotrexate—bone cancer	0.000231	0.00104	CcSEcCtD
Diltiazem—Chest pain—Doxorubicin—bone cancer	0.000231	0.00104	CcSEcCtD
Diltiazem—Myalgia—Doxorubicin—bone cancer	0.000231	0.00104	CcSEcCtD
Diltiazem—Arthralgia—Doxorubicin—bone cancer	0.000231	0.00104	CcSEcCtD
Diltiazem—CYP2D6—Doxorubicin—bone cancer	0.00023	0.144	CbGbCtD
Diltiazem—Paraesthesia—Methotrexate—bone cancer	0.00023	0.00104	CcSEcCtD
Diltiazem—Discomfort—Doxorubicin—bone cancer	0.000228	0.00103	CcSEcCtD
Diltiazem—Anorexia—Epirubicin—bone cancer	0.000228	0.00103	CcSEcCtD
Diltiazem—Dyspnoea—Methotrexate—bone cancer	0.000228	0.00103	CcSEcCtD
Diltiazem—Somnolence—Methotrexate—bone cancer	0.000227	0.00103	CcSEcCtD
Diltiazem—Dry mouth—Doxorubicin—bone cancer	0.000226	0.00102	CcSEcCtD
Diltiazem—Dyspepsia—Methotrexate—bone cancer	0.000225	0.00102	CcSEcCtD
Diltiazem—Hypotension—Epirubicin—bone cancer	0.000224	0.00101	CcSEcCtD
Diltiazem—Decreased appetite—Methotrexate—bone cancer	0.000222	0.001	CcSEcCtD
Diltiazem—Oedema—Doxorubicin—bone cancer	0.000221	0.001	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Methotrexate—bone cancer	0.000221	0.000997	CcSEcCtD
Diltiazem—Fatigue—Methotrexate—bone cancer	0.000221	0.000995	CcSEcCtD
Diltiazem—Infection—Doxorubicin—bone cancer	0.00022	0.000993	CcSEcCtD
Diltiazem—Pain—Methotrexate—bone cancer	0.000219	0.000987	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000218	0.000984	CcSEcCtD
Diltiazem—Shock—Doxorubicin—bone cancer	0.000218	0.000984	CcSEcCtD
Diltiazem—Nervous system disorder—Doxorubicin—bone cancer	0.000217	0.00098	CcSEcCtD
Diltiazem—Thrombocytopenia—Doxorubicin—bone cancer	0.000217	0.000979	CcSEcCtD
Diltiazem—Insomnia—Epirubicin—bone cancer	0.000217	0.000977	CcSEcCtD
Diltiazem—Tachycardia—Doxorubicin—bone cancer	0.000216	0.000976	CcSEcCtD
Diltiazem—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000215	0.00518	CbGpPWpGaD
Diltiazem—Paraesthesia—Epirubicin—bone cancer	0.000215	0.00097	CcSEcCtD
Diltiazem—Hyperhidrosis—Doxorubicin—bone cancer	0.000214	0.000967	CcSEcCtD
Diltiazem—Dyspnoea—Epirubicin—bone cancer	0.000213	0.000963	CcSEcCtD
Diltiazem—Somnolence—Epirubicin—bone cancer	0.000213	0.000961	CcSEcCtD
Diltiazem—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000212	0.00512	CbGpPWpGaD
Diltiazem—Anorexia—Doxorubicin—bone cancer	0.000211	0.000953	CcSEcCtD
Diltiazem—Feeling abnormal—Methotrexate—bone cancer	0.000211	0.000951	CcSEcCtD
Diltiazem—Dyspepsia—Epirubicin—bone cancer	0.000211	0.000951	CcSEcCtD
Diltiazem—Decreased appetite—Epirubicin—bone cancer	0.000208	0.000939	CcSEcCtD
Diltiazem—Hypotension—Doxorubicin—bone cancer	0.000207	0.000934	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Epirubicin—bone cancer	0.000207	0.000933	CcSEcCtD
Diltiazem—Fatigue—Epirubicin—bone cancer	0.000206	0.000932	CcSEcCtD
Diltiazem—Pain—Epirubicin—bone cancer	0.000205	0.000924	CcSEcCtD
Diltiazem—Constipation—Epirubicin—bone cancer	0.000205	0.000924	CcSEcCtD
Diltiazem—Urticaria—Methotrexate—bone cancer	0.000203	0.000917	CcSEcCtD
Diltiazem—Body temperature increased—Methotrexate—bone cancer	0.000202	0.000913	CcSEcCtD
Diltiazem—Abdominal pain—Methotrexate—bone cancer	0.000202	0.000913	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000202	0.000911	CcSEcCtD
Diltiazem—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000201	0.00485	CbGpPWpGaD
Diltiazem—Insomnia—Doxorubicin—bone cancer	0.0002	0.000904	CcSEcCtD
Diltiazem—Paraesthesia—Doxorubicin—bone cancer	0.000199	0.000898	CcSEcCtD
Diltiazem—Dyspnoea—Doxorubicin—bone cancer	0.000197	0.000891	CcSEcCtD
Diltiazem—Feeling abnormal—Epirubicin—bone cancer	0.000197	0.00089	CcSEcCtD
Diltiazem—Somnolence—Doxorubicin—bone cancer	0.000197	0.000889	CcSEcCtD
Diltiazem—Dyspepsia—Doxorubicin—bone cancer	0.000195	0.00088	CcSEcCtD
Diltiazem—Decreased appetite—Doxorubicin—bone cancer	0.000193	0.000869	CcSEcCtD
Diltiazem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000192	0.00463	CbGpPWpGaD
Diltiazem—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000191	0.000863	CcSEcCtD
Diltiazem—Fatigue—Doxorubicin—bone cancer	0.000191	0.000862	CcSEcCtD
Diltiazem—Urticaria—Epirubicin—bone cancer	0.00019	0.000858	CcSEcCtD
Diltiazem—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00019	0.00457	CbGpPWpGaD
Diltiazem—Constipation—Doxorubicin—bone cancer	0.000189	0.000855	CcSEcCtD
Diltiazem—Pain—Doxorubicin—bone cancer	0.000189	0.000855	CcSEcCtD
Diltiazem—Abdominal pain—Epirubicin—bone cancer	0.000189	0.000854	CcSEcCtD
Diltiazem—Body temperature increased—Epirubicin—bone cancer	0.000189	0.000854	CcSEcCtD
Diltiazem—Hypersensitivity—Methotrexate—bone cancer	0.000188	0.000851	CcSEcCtD
Diltiazem—CACNA1S—tendon—bone cancer	0.000186	0.0582	CbGeAlD
Diltiazem—Asthenia—Methotrexate—bone cancer	0.000184	0.000828	CcSEcCtD
Diltiazem—Feeling abnormal—Doxorubicin—bone cancer	0.000183	0.000824	CcSEcCtD
Diltiazem—Pruritus—Methotrexate—bone cancer	0.000181	0.000817	CcSEcCtD
Diltiazem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000177	0.00426	CbGpPWpGaD
Diltiazem—Hypersensitivity—Epirubicin—bone cancer	0.000176	0.000796	CcSEcCtD
Diltiazem—Urticaria—Doxorubicin—bone cancer	0.000176	0.000794	CcSEcCtD
Diltiazem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000175	0.00422	CbGpPWpGaD
Diltiazem—Body temperature increased—Doxorubicin—bone cancer	0.000175	0.00079	CcSEcCtD
Diltiazem—Abdominal pain—Doxorubicin—bone cancer	0.000175	0.00079	CcSEcCtD
Diltiazem—Diarrhoea—Methotrexate—bone cancer	0.000175	0.00079	CcSEcCtD
Diltiazem—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000174	0.0042	CbGpPWpGaD
Diltiazem—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000174	0.0042	CbGpPWpGaD
Diltiazem—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000173	0.00416	CbGpPWpGaD
Diltiazem—Asthenia—Epirubicin—bone cancer	0.000172	0.000775	CcSEcCtD
Diltiazem—Pruritus—Epirubicin—bone cancer	0.000169	0.000764	CcSEcCtD
Diltiazem—Dizziness—Methotrexate—bone cancer	0.000169	0.000764	CcSEcCtD
Diltiazem—CACNA1S—Alzheimers Disease—TP53—bone cancer	0.000167	0.00401	CbGpPWpGaD
Diltiazem—Diarrhoea—Epirubicin—bone cancer	0.000164	0.000739	CcSEcCtD
Diltiazem—Hypersensitivity—Doxorubicin—bone cancer	0.000163	0.000737	CcSEcCtD
Diltiazem—Vomiting—Methotrexate—bone cancer	0.000163	0.000734	CcSEcCtD
Diltiazem—Rash—Methotrexate—bone cancer	0.000161	0.000728	CcSEcCtD
Diltiazem—Dermatitis—Methotrexate—bone cancer	0.000161	0.000727	CcSEcCtD
Diltiazem—Headache—Methotrexate—bone cancer	0.00016	0.000723	CcSEcCtD
Diltiazem—Asthenia—Doxorubicin—bone cancer	0.000159	0.000717	CcSEcCtD
Diltiazem—Dizziness—Epirubicin—bone cancer	0.000158	0.000715	CcSEcCtD
Diltiazem—Pruritus—Doxorubicin—bone cancer	0.000157	0.000707	CcSEcCtD
Diltiazem—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000156	0.00375	CbGpPWpGaD
Diltiazem—Vomiting—Epirubicin—bone cancer	0.000152	0.000687	CcSEcCtD
Diltiazem—Nausea—Methotrexate—bone cancer	0.000152	0.000686	CcSEcCtD
Diltiazem—Diarrhoea—Doxorubicin—bone cancer	0.000152	0.000684	CcSEcCtD
Diltiazem—Rash—Epirubicin—bone cancer	0.000151	0.000681	CcSEcCtD
Diltiazem—Dermatitis—Epirubicin—bone cancer	0.000151	0.000681	CcSEcCtD
Diltiazem—Headache—Epirubicin—bone cancer	0.00015	0.000677	CcSEcCtD
Diltiazem—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000148	0.00357	CbGpPWpGaD
Diltiazem—Dizziness—Doxorubicin—bone cancer	0.000146	0.000661	CcSEcCtD
Diltiazem—CYP3A4—Doxorubicin—bone cancer	0.000146	0.0916	CbGbCtD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000146	0.00352	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NDUFA12—bone cancer	0.000145	0.00349	CbGpPWpGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000143	0.00345	CbGpPWpGaD
Diltiazem—Nausea—Epirubicin—bone cancer	0.000142	0.000642	CcSEcCtD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000142	0.00342	CbGpPWpGaD
Diltiazem—Vomiting—Doxorubicin—bone cancer	0.000141	0.000636	CcSEcCtD
Diltiazem—Rash—Doxorubicin—bone cancer	0.00014	0.00063	CcSEcCtD
Diltiazem—Dermatitis—Doxorubicin—bone cancer	0.00014	0.00063	CcSEcCtD
Diltiazem—Headache—Doxorubicin—bone cancer	0.000139	0.000626	CcSEcCtD
Diltiazem—Nausea—Doxorubicin—bone cancer	0.000132	0.000594	CcSEcCtD
Diltiazem—CACNA1C—connective tissue—bone cancer	0.000131	0.0411	CbGeAlD
Diltiazem—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000129	0.0031	CbGpPWpGaD
Diltiazem—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000127	0.00305	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MET—bone cancer	0.000127	0.00305	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000125	0.00301	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NT5C3A—bone cancer	0.00012	0.00289	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—TP53—bone cancer	0.000119	0.00286	CbGpPWpGaD
Diltiazem—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.00011	0.00266	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000107	0.00258	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MMP2—bone cancer	0.000106	0.00254	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000106	0.00254	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000105	0.00254	CbGpPWpGaD
Diltiazem—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	9.85e-05	0.00237	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—CYP3A4—bone cancer	9.27e-05	0.00223	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.15e-05	0.0022	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	9.14e-05	0.0022	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—CDK4—bone cancer	9.03e-05	0.00218	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MET—bone cancer	9.03e-05	0.00218	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MET—bone cancer	9.03e-05	0.00217	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	9.03e-05	0.00217	CbGpPWpGaD
Diltiazem—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.98e-05	0.00216	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	8.95e-05	0.00216	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NDUFA12—bone cancer	8.87e-05	0.00214	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP3A4—bone cancer	8.27e-05	0.00199	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	8.16e-05	0.00197	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.15e-05	0.00196	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MMP9—bone cancer	7.94e-05	0.00191	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—GSTP1—bone cancer	7.93e-05	0.00191	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.82e-05	0.00188	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.61e-05	0.00183	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—CYP3A4—bone cancer	7.54e-05	0.00182	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MMP2—bone cancer	7.53e-05	0.00181	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MMP2—bone cancer	7.53e-05	0.00181	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.5e-05	0.00181	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	7.44e-05	0.00179	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.43e-05	0.00179	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NT5C3A—bone cancer	7.35e-05	0.00177	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.32e-05	0.00176	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—GSTP1—bone cancer	7.08e-05	0.0017	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	6.98e-05	0.00168	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.94e-05	0.00167	CbGpPWpGaD
Diltiazem—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.57e-05	0.00158	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.51e-05	0.00157	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—GSTP1—bone cancer	6.45e-05	0.00155	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MET—bone cancer	6.44e-05	0.00155	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—CDK4—bone cancer	6.44e-05	0.00155	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.42e-05	0.00155	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NDUFA12—bone cancer	6.41e-05	0.00154	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—EGFR—bone cancer	6.41e-05	0.00154	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.36e-05	0.00153	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.21e-05	0.00149	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.19e-05	0.00149	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MMP9—bone cancer	5.66e-05	0.00136	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MMP9—bone cancer	5.66e-05	0.00136	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NDUFA12—bone cancer	5.56e-05	0.00134	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MMP2—bone cancer	5.38e-05	0.00129	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.34e-05	0.00129	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NT5C3A—bone cancer	5.31e-05	0.00128	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—ENO2—bone cancer	5.26e-05	0.00127	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NDUFA12—bone cancer	4.96e-05	0.00119	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—DHFR—bone cancer	4.88e-05	0.00118	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NDUFA12—bone cancer	4.84e-05	0.00117	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.6e-05	0.00111	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NT5C3A—bone cancer	4.6e-05	0.00111	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—EGFR—bone cancer	4.58e-05	0.0011	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—EGFR—bone cancer	4.57e-05	0.0011	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NDUFA12—bone cancer	4.56e-05	0.0011	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GNA11—bone cancer	4.56e-05	0.0011	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NDUFA12—bone cancer	4.52e-05	0.00109	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.25e-05	0.00102	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.2e-05	0.00101	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP3A4—bone cancer	4.13e-05	0.000996	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NT5C3A—bone cancer	4.11e-05	0.00099	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MMP9—bone cancer	4.04e-05	0.000973	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NT5C3A—bone cancer	4.01e-05	0.000966	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NT5C3A—bone cancer	3.78e-05	0.00091	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NT5C3A—bone cancer	3.75e-05	0.000902	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GSTP1—bone cancer	3.54e-05	0.000852	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.41e-05	0.000822	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.29e-05	0.000792	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EGFR—bone cancer	3.26e-05	0.000786	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—ENO2—bone cancer	3.22e-05	0.000776	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—DHFR—bone cancer	2.99e-05	0.00072	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NDUFA12—bone cancer	2.98e-05	0.000718	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.97e-05	0.000714	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GNA11—bone cancer	2.79e-05	0.000673	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP3A4—bone cancer	2.53e-05	0.00061	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NT5C3A—bone cancer	2.47e-05	0.000595	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.33e-05	0.000562	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—ENO2—bone cancer	2.33e-05	0.000561	CbGpPWpGaD
Diltiazem—ABCB1—bone marrow—bone cancer	2.28e-05	0.00714	CbGeAlD
Diltiazem—ABCB1—spinal cord—bone cancer	2.27e-05	0.00711	CbGeAlD
Diltiazem—CYP3A7—Metabolism—GSTP1—bone cancer	2.17e-05	0.000521	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—DHFR—bone cancer	2.16e-05	0.00052	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GNA11—bone cancer	2.02e-05	0.000486	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—ENO2—bone cancer	2.02e-05	0.000486	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.96e-05	0.000472	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—DHFR—bone cancer	1.87e-05	0.000451	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTGS2—bone cancer	1.83e-05	0.000441	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP3A4—bone cancer	1.83e-05	0.000441	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ENO2—bone cancer	1.8e-05	0.000433	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ENO2—bone cancer	1.76e-05	0.000423	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GNA11—bone cancer	1.75e-05	0.000421	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—DHFR—bone cancer	1.67e-05	0.000402	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ENO2—bone cancer	1.66e-05	0.000399	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ENO2—bone cancer	1.64e-05	0.000395	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—DHFR—bone cancer	1.63e-05	0.000392	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP3A4—bone cancer	1.59e-05	0.000382	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.58e-05	0.00038	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTP1—bone cancer	1.57e-05	0.000377	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GNA11—bone cancer	1.56e-05	0.000376	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—DHFR—bone cancer	1.54e-05	0.00037	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GNA11—bone cancer	1.52e-05	0.000367	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—DHFR—bone cancer	1.52e-05	0.000367	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GNA11—bone cancer	1.44e-05	0.000346	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GNA11—bone cancer	1.42e-05	0.000343	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP3A4—bone cancer	1.41e-05	0.000341	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.41e-05	0.000339	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000333	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTP1—bone cancer	1.36e-05	0.000326	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP3A4—bone cancer	1.3e-05	0.000313	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000311	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.28e-05	0.000309	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTP1—bone cancer	1.21e-05	0.000291	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTP1—bone cancer	1.18e-05	0.000284	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTGS2—bone cancer	1.12e-05	0.00027	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTP1—bone cancer	1.11e-05	0.000268	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTP1—bone cancer	1.1e-05	0.000266	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ENO2—bone cancer	1.08e-05	0.000261	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—DHFR—bone cancer	1e-05	0.000242	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GNA11—bone cancer	9.38e-06	0.000226	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTGS2—bone cancer	8.11e-06	0.000195	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTP1—bone cancer	7.28e-06	0.000175	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTGS2—bone cancer	7.02e-06	0.000169	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTGS2—bone cancer	6.27e-06	0.000151	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTGS2—bone cancer	6.12e-06	0.000147	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTGS2—bone cancer	5.77e-06	0.000139	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTGS2—bone cancer	5.72e-06	0.000138	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTGS2—bone cancer	3.77e-06	9.08e-05	CbGpPWpGaD
